S. 849 would authorize the Centers for Disease Control and Prevention (CDC) to undertake activities that would improve the collection of data on neurological diseases and conditions. It would also authorize CDC to begin collecting data for conditions that are among the five most prevalent neurological diseases.
CBO estimates that implementing S. 849 would cost $152 million over the 2017-2021 period, assuming appropriation of the necessary amounts. Enacting S. 849 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
CBO estimates that enacting the legislation would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2027.
S. 849 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.